Ad Hoc: Marinomed Biotech AG: Cessation of Operations and Closure of the Company
Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
Ad-hoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
Public Relations